Personalis, Inc. · 6 hours ago
Material Handler (Temp)
Personalis, Inc. is transforming the active management of cancer through breakthrough personalized testing. The Material Handler will be responsible for performing administrative and physical tasks involved in the receiving, storing, shipping, and distribution of materials needed to support the business offices and laboratories.
BiotechnologyGeneticsHealth CareHealth Diagnostics
Responsibilities
Receive, unpack, and check materials against purchase orders for damages, accuracy, and completeness
Label and put away incoming materials
Rotate inventory based on FIFO and Expiry
Performs routine cycle counts
Lifts heavy items up to 50 lbs
Enters data, maintains records in compliance with regulatory requirements (GMP and quality systems)
Maintain Laboratory KanBans
Maintains organized, safe & clean work environment
Collaborate with other Departments to ensure Warehouse is in alignment with future ISO and FDA requirements
Process weekly UN1845 and UN3373 shipments
Other duties as assigned
Qualification
Required
HS Diploma and 1 - 4 years relevant experience working in an Operations environment
Computer literate and able to work within Quality Systems, QAD or other ERP systems
Self-motivated, detail oriented, able to communicate and function effectively in a team environment
Preferred
Experience in a GMP, FDA, or ISO 13485 regulated environment highly desired
Valid IATA Dangerous Goods Certification highly desired
Experience in processing and monitoring inbound and outbound shipments highly desired
Benefits
Medical
Dental
Vision
401(k) match
ESPP
Tuition reimbursement
Sick/vacation time
Commuter benefits/ EV charging stations
Onsite gym
Wellness benefits
Company
Personalis, Inc.
At Personalis, we are transforming the active management of cancer through breakthrough personalized testing.
Funding
Current Stage
Public CompanyTotal Funding
$311.25MKey Investors
MerckTempusLightspeed Venture Partners
2024-12-19Post Ipo Equity· $50M
2024-08-16Post Ipo Equity· $36.15M
2021-01-27Post Ipo Equity· $150.1M
Recent News
2026-01-09
2026-01-09
Company data provided by crunchbase